Purchase Order 36C25225P1167

The U.S. Department of Veterans Affairs' Veterans Integrated Service Network 12 awarded a firm fixed-price purchase order valued at $49,748.73 to Novocure Inc. for medical devices, with an ultimate completion date of May 30, 2025. The award was issued without a set-aside designation and represents a delivery order under Novocure's existing Federal Supply Schedule contract with the VA Veterans Health Administration. The performance location is Portsmouth, New Hampshire. Novocure Inc., a foreign-owned medical device manufacturer, specializes in the Optune system, which utilizes Tumor Treating Fields technology to treat solid tumor cancers including glioblastoma and mesothelioma. The company's FDA-approved devices provide non-invasive cancer treatment options for veteran patients across VA medical centers nationwide.

This purchase order is executed under Novocure's broader Federal Supply Schedule contract (FSS-65-II-A, Medical Equipment and Supplies category) valued at $28.85 million, which was awarded on November 1, 2022, and extends through October 31, 2027. Through this multiple-award FSS vehicle, various Veterans Integrated Service Networks issue delivery orders to procure Novocure's Optune TTFields therapy products and related support services. As the prime contractor, Novocure delivers its proprietary medical device technologies directly to VA facilities without employing subcontractors. These contracts support the VA's mission of expanding veteran access to cutting-edge cancer treatment technologies.